Ann Lab Med.  2013 Jan;33(1):84-85. 10.3343/alm.2013.33.1.84.

First Detection of VIM-4 Metallo-beta-Lactamase-Producing Citrobacter freundii in China

• Wei Y
• Wang J

• KMID: 1781304
• DOI: http://doi.org/10.3343/alm.2013.33.1.84

Abstract

No abstract available.

MeSH Terms

Aged
Anti-Bacterial Agents/pharmacology/therapeutic use
Cefotaxime/therapeutic use
China
Ciprofloxacin/therapeutic use
Citrobacter freundii/drug effects/*enzymology/isolation & purification
Drug Resistance, Multiple, Bacterial
Humans
Imipenem/pharmacology
Male
Microbial Sensitivity Tests
Respiratory Tract Infections/*diagnosis/drug therapy/microbiology
Thienamycins/pharmacology
beta-Lactamases/*metabolism
Anti-Bacterial Agents
Thienamycins
Cefotaxime
Imipenem
Ciprofloxacin
beta-Lactamases

Reference

1. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect Dis. 2011; 11:381–393. PMID: 21530894.

2. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev. 2007; 20:440–458. PMID: 17630334.

3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-Second Informational supplement, M100-S22. 2012. Wayne, PA: Clinical and Laboratory Standards Institute.

4. Yan JJ, Hsueh PR, Ko WC, Luh KT, Tsai SH, Wu HM, et al. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother. 2001; 45:2224–2228. PMID: 11451678.

5. Doran TI. The role of Citrobacter in clinical disease of children: review. Clin Infect Dis. 1999; 28:384–394. PMID: 10064257.

6. Pournaras S, Tsakris A, Maniati M, Tzouvelekis LS, Maniatis AN. Novel variant (bla(VIM-4)) of the metallo-β-lactamase gene bla(VIM-1) in a clinical strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2002; 46:4026–4028. PMID: 12435718.